Biocon: Biocon's board OKs to raise Rs 4,500-cr
Biocon said that its board has approved raising up to Rs 4,500 crore, via multiple instruments through different routes.
Read full article »
CEO
- -Biocon is an India-based biopharmaceutical company that develops and commercializes novel therapeutics for the treatment of diabetes, cancer and autoimmune diseases.
Read more